GDRX
GoodRx Holdings
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: GDRX
- PE Ratio
The PE ratio for GoodRx Holdings stock stands at 46.83 as of Jun 3, 2026. This takes into account the latest EPS of $0.06 and stock price of $2.81. An increase of 10% has been observed in the PE ratio compared to its average of 42.7 of the last four quarters.
GDRX PE ratio history
Over the last three years, the average PE ratio of GoodRx Holdings has been 101.74. The current 46.83 P/E ratio is 54% lower than the historical average. Looking back at the last three years, GDRX's PE ratio peaked in the Jun 2023 quarter at 276, with a price of $5.52 and an EPS of $0.02. The Dec 2025 quarter marked the lowest point at 30.11, with a price of $2.71 and an EPS of $0.09.
GoodRx Holdings PE ratio by year
Maximum annual decrease: -74.1% in 2025
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 30.11 | -74.1% | $2.71 | $0.09 |
| 2024 | 116.25 | N/A | $4.65 | $0.04 |
| 2023 | N/A | N/A | $6.7 | -$0.02 |
| 2022 | N/A | N/A | $4.66 | -$0.08 |
| 2021 | N/A | N/A | $32.68 | -$0.06 |
| 2020 | N/A | N/A | $40.34 | -$1.07 |
| 2019 | N/A | N/A | N/A | $0.19 |
| 2018 | N/A | N/A | N/A | $0.12 |
GoodRx Holdings PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 32.67 | 8.5% | $1.96 | $0.06 |
| Dec 2025 | 30.11 | -43.06% | $2.71 | $0.09 |
| Sep 2025 | 52.88 | -4.43% | $4.23 | $0.08 |
| Jun 2025 | 55.33 | -12.17% | $4.98 | $0.09 |
| Mar 2025 | 63 | -45.81% | $4.41 | $0.07 |
| Dec 2024 | 116.25 | N/A | $4.65 | $0.04 |
| Sep 2024 | N/A | N/A | $6.94 | -$0.03 |
| Jun 2024 | N/A | N/A | $7.8 | -$0.13 |
| Mar 2024 | N/A | N/A | $7.1 | -$0.01 |
| Dec 2023 | N/A | N/A | $6.7 | -$0.02 |
| Sep 2023 | 187.67 | -32% | $5.63 | $0.03 |
| Jun 2023 | 276 | N/A | $5.52 | $0.02 |
| Mar 2023 | N/A | N/A | $6.25 | -$0.12 |
| Dec 2022 | N/A | N/A | $4.66 | -$0.08 |
| Sep 2022 | N/A | N/A | $4.67 | -$0.17 |
GDRX Price vs fair value
GDRX average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
GDRX's current PE ratio is lower than its 3 and 5-year averages.
PE comparison
GoodRx Holdings's price to earnings (P/E) of 46.83 is higher than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 23.02, GoodRx Holdings's price to earnings (P/E) is 103% higher.
GDRX PE vs peers
In comparison to its peer stock PINS, GDRX's PE ratio is higher.
| Stock name | PE ratio | Market cap |
|---|---|---|
| PINS Pinterest Inc | 44.04 | $12.09B |
| GDRX GoodRx Holdings Inc | 47.33 | $961.84M |
Frequently asked questions
What is GoodRx Holdings's PE ratio?
The price to earnings ratio for GDRX stock is 46.83 as of Jun 3, 2026.
What is the 3-year average PE ratio for GoodRx Holdings (GDRX)?
The 3-year average price to earnings ratio for GDRX stock is 101.74.
What is the 5-year average PE ratio for GoodRx Holdings (GDRX)?
The 5-year average price to earnings ratio for GDRX stock is 101.74.
What is the highest PE ratio for GDRX?
The highest quarterly PE ratio in the last three years has been 276 and it was in the Jun 2023 quarter.
How does the current PE ratio for GDRX compare to its historical average?
GDRX's price to earnings ratio is currently 54% below its 3-year historical average.
How is GDRX's PE ratio calculated (GoodRx Holdings PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 3, 2026), GoodRx Holdings's share price is $2.81. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $0.06. Therefore, GoodRx Holdings's PE ratio for today is 46.83. PE RATIO(46.83) = STOCK PRICE($2.81) / TTM EPS($0.06)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.